https://orris.care/shared/chat/9d7ec2df-db07-4ffe-bea3-5532715ad120 this is my previous chat can you continue
https://orris.care/shared/chat/9d7ec2df-db07-4ffe-bea3-55327β¦
rabies global mortality incidence statistics 2024 WHO CDC exact numbers
rabies epidemiology global burden incidence mortality
https://www.who.int/news-room/fact-sheets/detail/rabies
rabies epidemiology global burden mortality statistics
do you have other simpler but unique disease with exact data and numbers from valid and reliable resources
| If you want... | Pick |
|---|---|
| Most unique / professor never seen it | Noma |
| Best data / easiest to fill all fields | Dengue |
| Most current / in the news right now | Cholera |
| Good balance of unique + data available | Schistosomiasis |
best data available
more options
| Disease | Key Stat | Unique Angle |
|---|---|---|
| Measles | 9 million cases, 136,000 deaths in 2023 (WHO) | Resurgence despite vaccine; herd immunity concept |
| Pertussis (Whooping Cough) | ~24.1 million cases/year; 160,700 deaths/year | Waning vaccine immunity; affects infants most |
| Tuberculosis | 10.6 million cases, 1.13 million deaths in 2023 (WHO) | Largest single infectious disease killer globally |
| Disease | Key Stat | Unique Angle |
|---|---|---|
| Dengue (previous pick) | 390 million infections/year | 8x increase in 20 years |
| Chikungunya | 5 million cases/year; spreading to new continents | Emerged in Europe/Americas recently |
| Leishmaniasis | 700,000-1 million new cases/year; 26,000-65,000 deaths | Sandfly-transmitted; very under-recognized |
| African Sleeping Sickness | ~1,000 cases/year now (near elimination) | Dramatic success story - cases dropped 97% |
| Disease | Key Stat | Unique Angle |
|---|---|---|
| Cholera | 1.3-4 million cases/year; resurging 2022-2024 | WASH public health angle |
| Typhoid Fever | 9-11 million cases/year; 110,000 deaths/year | Drug-resistant strains emerging |
| Hepatitis A | ~1.4 million cases/year globally | Vaccine-preventable; linked to sanitation |
| Disease | Key Stat | Unique Angle |
|---|---|---|
| Tetanus | 56,000 deaths/year; 34,000 neonatal deaths | Not herd-immunity dependent - spores live forever in soil |
| Leptospirosis | ~1 million severe cases/year; 58,900 deaths/year | Linked to floods/climate change; very current |
| Hookworm (Soil-transmitted helminth) | 472 million infected globally | Simple life cycle; poverty-linked |
| Disease | Key Stat | Unique Angle |
|---|---|---|
| Noma (previous pick) | 140,000 cases/year; WHO listed as NTD in 2023 | Very unique, professor likely unfamiliar |
| Mpox | 99,176 confirmed cases in 2024 (WHO) | Active outbreak; Clade I declared PHEIC 2024 |
| Hantavirus (your original) | ~200,000 cases/year HFRS + ~300 HPS/year | In the news, rodent-borne |
| Lassa Fever | 100,000-300,000 cases/year; CFR 15-25% in hospitalized | Hemorrhagic fever; West Africa endemic |
| Your priority | Best pick |
|---|---|
| Easiest to fill all 8 fields | Tuberculosis or Measles |
| Most current / newsworthy | Mpox or Cholera |
| Most unique / stands out | Noma or African Sleeping Sickness |
| Interesting transmission story | Leptospirosis or Tetanus |
| Best overall data + uniqueness balance | Typhoid Fever or Leptospirosis |
Mpox
Mpox monkeypox global cases deaths statistics 2024 2025 WHO exact numbers
mpox monkeypox epidemiology global burden 2024
https://www.who.int/news-room/fact-sheets/detail/mpox
mpox age distribution sex male female children CFR case fatality rate 2024 descriptive epidemiology
this is way too big information I wanted short
this subtypes clade is making it difficult, something simple straightforward
| Disease | Transmission | One-line summary |
|---|---|---|
| Cholera | Contaminated water/food | Diarrheal disease; very clear WASH public health angle |
| Measles | Airborne droplets | Vaccine-preventable; strong resurgence data 2023-2024 |
| Tetanus | Wound contamination (soil spores) | Not contagious at all; unique epidemiology |
| Typhoid Fever | Contaminated food/water | Clear global burden; drug-resistant strains emerging |
| Leptospirosis | Contact with animal urine (water/soil) | Linked to floods; very simple life cycle |
| Pertussis (Whooping Cough) | Airborne droplets | Simple, well-documented; waning vaccine immunity angle |
| Schistosomiasis | Freshwater snail contact | Unique transmission; very clean WHO data |
| Leishmaniasis | Sandfly bite | Simple vector; clear geographic data |
which is better pertussis or leishmaniasis [ simple and good data]
| Criteria | Pertussis (Whooping Cough) | Leishmaniasis |
|---|---|---|
| Causative agent | Bordetella pertussis - one bacterium | 3 forms (cutaneous, visceral, mucocutaneous) - slightly complex |
| Transmission | Airborne droplets - very simple | Sandfly bite - simple and unique |
| Data availability | Excellent - CDC/WHO track every year | Good - WHO tracks but some underreporting |
| Exact numbers | WHO: 24.1 million cases/year, 160,700 deaths/year | WHO: 700,000-1 million cases/year, 26,000-65,000 deaths/year |
| Age/sex data | Very clear - infants most at risk, clear age breakdown | Clear - poverty-linked, some geographic data |
| Geographic data | Global - every country affected | Limited to 90 countries, mostly tropics/subtropics |
| Trend data | Strong - resurgence despite vaccination is a great story | Moderate |
| Public health programs | Very clear - DTP/DTaP vaccine, schedule, coverage data | Less well-known programs |
| "Unique" factor | Common but interesting angle: waning immunity means vaccinated people still get it | More unique - most professors won't see it often |
| Simplicity | Very simple - one pathogen, one route | Slightly complex - 3 clinical forms |
Build short pertussis fact sheet (all 8 fields)
pertussis whooping cough global incidence mortality statistics 2023 2024 WHO CDC exact numbers
pertussis age distribution infants adults risk factors vaccine coverage descriptive epidemiology
| Metric | Figure | Source |
|---|---|---|
| Global cases (2024, reported to WHO) | 941,565 | WHO/CDC 2024 |
| Estimated global cases/year (all ages) | ~24.1 million | WHO/CDC estimate |
| Estimated deaths/year (children <5) | 160,700 | WHO/CDC estimate |
| US cases in 2024 | 35,435 | CDC Surveillance Report 2024 |
| US cases in 2023 (for comparison) | 7,063 | CDC |
| US incidence rate (2024) | 10.6 per 100,000 | CDC |
| Infants under 6 months incidence (USA) | 85.4 per 100,000 | CDC 2024 |
| % US cases hospitalized (infants <6 mo) | 33.4% | CDC 2024 |
| Infant deaths in USA (2024) | 6 | StatPearls/CDC |
| Vaccine | Schedule |
|---|---|
| DTaP (children) | 5 doses: ages 2, 4, 6 months; 15-18 months; 4-6 years |
| Tdap (adolescents/adults) | 1 booster dose at age 11-12; then every 10 years |
| Tdap in pregnancy | 1 dose every pregnancy (27-36 weeks) - protects newborn before their own vaccines |
can you focus on Georgia[country] and india instead of USA in data
pertussis whooping cough Georgia country cases incidence statistics 2022 2023 2024
pertussis whooping cough India cases incidence statistics 2022 2023 2024 WHO
pertussis Georgia country Europe WHO reported cases 2022 2023 2024 incidence per 100000
pertussis India reported cases 2023 2024 WHO UNICEF DTP3 vaccine coverage burden
| Option | Data quality |
|---|---|
| Keep global + Europe data | Excellent - ECDC 2024 report has exact numbers |
| Add India | Only vaccine coverage data available; no reliable case counts |
| Add Georgia country | No reliable country-specific data found |
what id difference in global cases and estimated global cases
| Reported/Confirmed Cases | Estimated Cases | |
|---|---|---|
| What it is | Cases officially diagnosed and reported to WHO/CDC by countries | Scientific calculation of the TRUE number of cases including unreported ones |
| How it's obtained | Country health ministries submit data to WHO every year | Researchers use mathematical models, serological surveys, and extrapolation |
| Example (Pertussis) | 941,565 cases reported to WHO in 2024 | ~24.1 million cases estimated per year |
| Who produces it | WHO surveillance system | Independent researchers / modelling studies |
| Is it exact? | No - still incomplete, but it's the official count | No - it's a best-guess range based on evidence |
Reported cases = the tip of the iceberg (what we can see and count) Estimated cases = the whole iceberg (the true burden including hidden cases)
Generate a Word document with your complete pertussis fact sheet
ls /home/daytona/workspace/ 2>/dev/null && ls /home/daytona/skills/docx/scripts/office/ 2>/dev/null
mkdir -p /home/daytona/workspace/pertussis-factsheet
~/pertussis-factsheet/generate.js
const {
Document, Packer, Paragraph, TextRun, Table, TableRow, TableCell,
HeadingLevel, AlignmentType, BorderStyle, WidthType, ShadingType,
VerticalAlign, PageNumber, Header, Footer
} = require('docx');
const fs = require('fs');
// ---- Colour palette ----
const BLUE = "1F4E79"; // dark blue - title / section headers
const LIGHTBLUE = "D6E4F0"; // light blue - table header fill
const MIDBLUE = "2E75B6"; // mid blue - field headings
const WHITE = "FFFFFF";
const DARKGRAY = "404040";
const BLACK = "000000";
// ---- Helper: bold coloured heading paragraph ----
function sectionHeading(text) {
return new Paragraph({
spacing: { before: 260, after: 80 },
shading: { type: ShadingType.SOLID, color: MIDBLUE, fill: MIDBLUE },
children: [
new TextRun({
text: ` ${text}`,
bold: true,
color: WHITE,
size: 24,
font: "Calibri",
}),
],
});
}
// ---- Helper: normal body paragraph ----
function body(text, opts = {}) {
return new Paragraph({
spacing: { before: 60, after: 60 },
children: [
new TextRun({
text,
size: 20,
font: "Calibri",
color: DARKGRAY,
bold: opts.bold || false,
italics: opts.italic || false,
}),
],
});
}
// ---- Helper: bullet ----
function bullet(text, boldPart) {
const runs = [];
if (boldPart) {
runs.push(new TextRun({ text: boldPart, bold: true, size: 20, font: "Calibri", color: DARKGRAY }));
runs.push(new TextRun({ text: text, size: 20, font: "Calibri", color: DARKGRAY }));
} else {
runs.push(new TextRun({ text, size: 20, font: "Calibri", color: DARKGRAY }));
}
return new Paragraph({
bullet: { level: 0 },
spacing: { before: 40, after: 40 },
children: runs,
});
}
// ---- Helper: sub-bullet ----
function subBullet(text) {
return new Paragraph({
bullet: { level: 1 },
spacing: { before: 30, after: 30 },
children: [new TextRun({ text, size: 20, font: "Calibri", color: DARKGRAY })],
});
}
// ---- Helper: small bold label ----
function subHeading(text) {
return new Paragraph({
spacing: { before: 140, after: 50 },
children: [new TextRun({ text, bold: true, size: 21, font: "Calibri", color: BLUE })],
});
}
// ---- Helper: simple 2-col table ----
function twoColTable(rows, headerRow) {
const tableRows = [];
if (headerRow) {
tableRows.push(new TableRow({
tableHeader: true,
children: headerRow.map(h =>
new TableCell({
shading: { type: ShadingType.SOLID, color: LIGHTBLUE, fill: LIGHTBLUE },
verticalAlign: VerticalAlign.CENTER,
children: [new Paragraph({
children: [new TextRun({ text: h, bold: true, size: 20, font: "Calibri", color: BLUE })],
})],
})
),
}));
}
rows.forEach(([col1, col2], i) => {
const fill = i % 2 === 0 ? "F5F9FD" : WHITE;
tableRows.push(new TableRow({
children: [
new TableCell({
width: { size: 35, type: WidthType.PERCENTAGE },
shading: { type: ShadingType.SOLID, color: fill, fill },
children: [new Paragraph({
children: [new TextRun({ text: col1, bold: true, size: 19, font: "Calibri", color: DARKGRAY })],
})],
}),
new TableCell({
width: { size: 65, type: WidthType.PERCENTAGE },
shading: { type: ShadingType.SOLID, color: fill, fill },
children: [new Paragraph({
children: [new TextRun({ text: col2, size: 19, font: "Calibri", color: DARKGRAY })],
})],
}),
],
}));
});
return new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: tableRows,
borders: {
top: { style: BorderStyle.SINGLE, size: 1, color: "BDD7EE" },
bottom: { style: BorderStyle.SINGLE, size: 1, color: "BDD7EE" },
left: { style: BorderStyle.SINGLE, size: 1, color: "BDD7EE" },
right: { style: BorderStyle.SINGLE, size: 1, color: "BDD7EE" },
insideH:{ style: BorderStyle.SINGLE, size: 1, color: "BDD7EE" },
insideV:{ style: BorderStyle.SINGLE, size: 1, color: "BDD7EE" },
},
});
}
// ---- Helper: spacer ----
function spacer() {
return new Paragraph({ spacing: { before: 80, after: 80 }, children: [new TextRun("")] });
}
// ================================================================
// DOCUMENT CONTENT
// ================================================================
const doc = new Document({
styles: {
default: {
document: {
run: { font: "Calibri", size: 20, color: DARKGRAY },
},
},
},
sections: [{
properties: {
page: {
margin: { top: 720, bottom: 720, left: 900, right: 900 },
},
},
headers: {
default: new Header({
children: [
new Paragraph({
alignment: AlignmentType.RIGHT,
children: [
new TextRun({ text: "Pertussis (Whooping Cough) | Epidemiology Fact Sheet", size: 16, color: "888888", font: "Calibri" }),
],
}),
],
}),
},
footers: {
default: new Footer({
children: [
new Paragraph({
alignment: AlignmentType.CENTER,
children: [
new TextRun({ text: "Sources: WHO | CDC | ECDC | StatPearls | PMC Page ", size: 16, color: "888888", font: "Calibri" }),
new TextRun({ children: [PageNumber.CURRENT], size: 16, color: "888888", font: "Calibri" }),
],
}),
],
}),
},
children: [
// ββ TITLE BLOCK ββββββββββββββββββββββββββββββββββββββββββ
new Paragraph({
alignment: AlignmentType.CENTER,
spacing: { before: 0, after: 40 },
shading: { type: ShadingType.SOLID, color: BLUE, fill: BLUE },
children: [
new TextRun({ text: "PERTUSSIS", bold: true, size: 52, color: WHITE, font: "Calibri" }),
],
}),
new Paragraph({
alignment: AlignmentType.CENTER,
spacing: { before: 0, after: 20 },
shading: { type: ShadingType.SOLID, color: MIDBLUE, fill: MIDBLUE },
children: [
new TextRun({ text: "(Whooping Cough)", bold: false, size: 28, color: WHITE, font: "Calibri" }),
],
}),
new Paragraph({
alignment: AlignmentType.CENTER,
spacing: { before: 0, after: 200 },
shading: { type: ShadingType.SOLID, color: MIDBLUE, fill: MIDBLUE },
children: [
new TextRun({ text: "Epidemiology Fact Sheet", bold: true, size: 22, color: "D6E4F0", font: "Calibri" }),
],
}),
// ββ FIELD 1: DISEASE OVERVIEW ββββββββββββββββββββββββββββ
sectionHeading("1. DISEASE OVERVIEW"),
spacer(),
twoColTable([
["Disease Name", "Pertussis (Whooping Cough)"],
["Causative Agent", "Bordetella pertussis (gram-negative bacterium)"],
["Type", "Acute bacterial respiratory disease; vaccine-preventable"],
["Transmission Route", "Respiratory droplets (coughing/sneezing); extremely contagious"],
["Incubation Period", "7β10 days (range: 4β21 days)"],
["Infectious Period", "From symptom onset up to 3 weeks if untreated"],
["Case Fatality Rate", "<1% overall; up to 1β2% in infants under 6 months"],
["Vaccine-Preventable?","Yes β DTaP (children), Tdap (adolescents/adults)"],
["Notifiable Disease?", "Yes, in most countries; notifiable to WHO"],
], ["Item", "Detail"]),
spacer(),
// ββ FIELD 2: EPIDEMIOLOGY DATA βββββββββββββββββββββββββββ
sectionHeading("2. EPIDEMIOLOGY DATA"),
spacer(),
twoColTable([
["Global cases reported to WHO (2024)", "941,565 confirmed cases"],
["Estimated true global cases/year", "~24.1 million cases (all ages)"],
["Why the gap?", "Massive underreporting β adults/teens misdiagnosed as bronchitis; limited lab capacity in LMICs"],
["Estimated deaths/year (children <5)", "160,700 deaths"],
["Global incidence (2024)", "~137 per 1,000,000 population"],
["Global DTP3 vaccine coverage (2024)", "85% of infants worldwide (WHO)"],
["Unvaccinated children globally (2024)", "14.3 million zero-dose children (WHO)"],
["Europe incidence rate (2024)", "54.9 per 100,000 β 8Γ increase from 2023 (ECDC)"],
["Rβ (Basic Reproduction Number)", "12β17 β among the most contagious diseases known"],
], ["Metric", "Figure / Detail"]),
spacer(),
// ββ FIELD 3: DESCRIPTIVE EPIDEMIOLOGY βββββββββββββββββββ
sectionHeading("3. DESCRIPTIVE EPIDEMIOLOGY"),
subHeading("Person"),
twoColTable([
["Most vulnerable age", "Infants <6 months β incidence 85.4/100,000; hospitalization rate 33.4% (CDC 2024)"],
["Age shift (recent trend)", "Immunity wanes 4β12 years post-vaccine β teens & adults now major reservoir"],
["Sex", "Slightly higher incidence & mortality in females, especially in infants"],
["Immunocompromised", "Higher risk of severe disease and complications"],
], ["Factor", "Detail"]),
subHeading("Place"),
twoColTable([
["Highest global burden", "Low-income countries in Asia, Africa, and Latin America β poor vaccination coverage & lab capacity"],
["Europe 2024", "54.9 cases/100,000; infants <1 yr (318.5/100,000) and adolescents 10β14 yrs (204.2/100,000) most affected (ECDC)"],
["India / South Asia", "Among top 10 countries with highest unvaccinated children; pertussis severely underreported"],
["High-income countries", "Resurgence in UK, USA, Australia, France, Denmark, Korea despite high vaccination rates"],
], ["Factor", "Detail"]),
subHeading("Time"),
twoColTable([
["First case documented", "1906 β Bordetella pertussis isolated by Bordet & Gengou"],
["Vaccine introduced", "1940s (whole-cell wP vaccine); acellular aP vaccine from 1990s"],
["Cyclical pattern", "Peaks every 3β5 years; cyclical resurgence is characteristic"],
["Post-COVID surge", "2024: global cases 476% higher than 2023; Europe 8Γ surge; USA 5Γ surge"],
["Current trend (2026)", "Declining after November 2024 peak β consistent with cyclical pattern (CDC)"],
], ["Factor", "Detail"]),
spacer(),
// ββ FIELD 4: RISK FACTORS ββββββββββββββββββββββββββββββββ
sectionHeading("4. RISK FACTORS"),
spacer(),
bullet("Infants under 6 months", ""),
subBullet("Not yet fully vaccinated; highest incidence and death rate"),
bullet("Unvaccinated or incompletely vaccinated individuals", ""),
bullet("Waning vaccine immunity", ""),
subBullet("DTaP/Tdap protection lasts only 4β12 years β teens and adults lose protection over time"),
bullet("Household or close contact with a confirmed case", ""),
bullet("Pregnancy", ""),
subBullet("Infected mothers can transmit to newborns before their vaccines begin; also higher complication risk"),
bullet("Immunocompromised status or chronic respiratory disease (asthma, COPD)", ""),
bullet("Low community vaccine coverage", ""),
subBullet("Reduces herd immunity threshold, allowing outbreaks even in vaccinated populations"),
bullet("Healthcare workers", ""),
subBullet("Occupational exposure risk; can transmit to vulnerable patients if unprotected"),
spacer(),
// ββ FIELD 5: TRANSMISSION & PUBLIC HEALTH IMPACT ββββββββ
sectionHeading("5. TRANSMISSION & PUBLIC HEALTH IMPACT"),
subHeading("Transmission"),
twoColTable([
["Primary route", "Respiratory droplets from coughing or sneezing"],
["Rβ", "12β17; one of the highest reproduction numbers of any known infectious disease"],
["Contagious period", "From symptom onset up to 3 weeks if untreated; antibiotics reduce this significantly"],
["Asymptomatic spread", "Teens and adults often spread unknowingly β present with mild prolonged cough only"],
["NOT spread via", "Fomites (surfaces); not considered a significant environmental route"],
], ["Mode", "Detail"]),
subHeading("Public Health Impact"),
bullet("~24.1 million cases/year globally; 160,700 child deaths/year β one of the leading vaccine-preventable killers"),
bullet("63% of infected infants under 12 months in the USA were hospitalized (CDC data)"),
bullet("Post-COVID surge: global cases in 2024 were 476% higher than 2023 (WHO)"),
bullet("Waning immunity means even well-vaccinated countries experience outbreaks β challenges traditional herd immunity models"),
bullet("Significant healthcare costs from infant hospitalizations (median stay: 5 days)"),
bullet("Estimated 5 undetected cases for every 1 clinically diagnosed adolescent/adult case"),
spacer(),
// ββ FIELD 6: CONTROL & MANAGEMENT / PREVENTION ββββββββββ
sectionHeading("6. CONTROL & MANAGEMENT / PREVENTION"),
subHeading("Treatment"),
twoColTable([
["Antibiotic of choice", "Azithromycin (1st line); alternatives: clarithromycin, TMP-SMX"],
["When to treat", "Most effective in early catarrhal stage (first 1β2 weeks); still given later to reduce spread"],
["Supportive care", "Rest, fluids, small frequent feeds for infants; avoid cough suppressants in infants"],
["Hospitalization", "Required for infants with apnea, oxygen needs, or feeding difficulties"],
], ["Item", "Detail"]),
subHeading("Vaccination Schedule"),
twoColTable([
["DTaP (infants/children)", "5 doses: at 2, 4, 6 months; 15β18 months; 4β6 years"],
["Tdap (adolescents)", "1 booster at age 11β12; then every 10 years"],
["Tdap in pregnancy", "1 dose every pregnancy at 27β36 weeks β protects newborn before their own vaccines"],
["DTaP coverage (global)", "85% of infants received β₯3 doses (DTP3) in 2024 β WHO"],
["Adult Tdap gap", "Only ~31.7% coverage in US adults β major driver of adult-to-infant transmission"],
], ["Vaccine", "Details"]),
subHeading("Public Health Programs"),
bullet("WHO Expanded Programme on Immunization (EPI)", ""),
subBullet("Global DTP vaccination initiative targeting infants in all countries"),
bullet("Cocoon Strategy", ""),
subBullet("Vaccinating parents, siblings, and caregivers to protect newborns before their vaccines"),
bullet("Maternal Tdap", ""),
subBullet("WHO and CDC recommend 1 dose per pregnancy β most effective strategy for protecting young infants"),
bullet("Contact tracing", ""),
subBullet("All household contacts given prophylactic antibiotics; 21-day symptom monitoring"),
bullet("Gavi Vaccine Alliance", ""),
subBullet("Funds DTP vaccines in 57 lower-income countries"),
spacer(),
// ββ FIELD 7: QUICK FACTS βββββββββββββββββββββββββββββββββ
sectionHeading("7. QUICK FACTS / DID YOU KNOW?"),
spacer(),
bullet('Known as the "100-day cough" in Chinese medicine β coughing fits can last up to 3 months'),
bullet("Despite >90% vaccination rates globally, pertussis CANNOT be eliminated because vaccine immunity wanes"),
bullet("The 2024 global surge was 476% higher than 2023 β the largest post-COVID resurgence recorded"),
bullet("Teens and adults are the hidden reservoir β they spread it to vulnerable infants while thinking they just have a bad cold"),
bullet("For every 1 diagnosed adolescent/adult case, there are an estimated ~5 undetected cases"),
bullet("The whooping sound is heard mainly in children β adults rarely whoop, making diagnosis much harder"),
bullet("Rβ of 12β17 means one infected person can infect up to 17 others β as contagious as measles"),
bullet("Reported cases (941,565 in 2024) represent only the tip of the iceberg β true burden estimated at ~24.1 million/year"),
spacer(),
// ββ FIELD 8: SOURCES βββββββββββββββββββββββββββββββββββββ
sectionHeading("8. SOURCES"),
spacer(),
new Paragraph({
spacing: { before: 60, after: 60 },
children: [new TextRun({ text: "1. WHO Immunization Coverage Fact Sheet (2025). who.int/news-room/fact-sheets/detail/immunization-coverage", size: 18, font: "Calibri", color: DARKGRAY })],
}),
new Paragraph({
spacing: { before: 60, after: 60 },
children: [new TextRun({ text: "2. CDC β 2024 Provisional Pertussis Surveillance Report (January 2025). cdc.gov/pertussis", size: 18, font: "Calibri", color: DARKGRAY })],
}),
new Paragraph({
spacing: { before: 60, after: 60 },
children: [new TextRun({ text: "3. CDC β Pertussis in Other Countries. cdc.gov/pertussis/php/global/index.html", size: 18, font: "Calibri", color: DARKGRAY })],
}),
new Paragraph({
spacing: { before: 60, after: 60 },
children: [new TextRun({ text: "4. CDC Pink Book β Chapter 16: Pertussis. cdc.gov/pinkbook/hcp/table-of-contents/chapter-16-pertussis.html", size: 18, font: "Calibri", color: DARKGRAY })],
}),
new Paragraph({
spacing: { before: 60, after: 60 },
children: [new TextRun({ text: "5. ECDC β Pertussis Annual Epidemiological Report for 2024. ecdc.europa.eu", size: 18, font: "Calibri", color: DARKGRAY })],
}),
new Paragraph({
spacing: { before: 60, after: 60 },
children: [new TextRun({ text: "6. StatPearls/NCBI β Pertussis (updated 2024). ncbi.nlm.nih.gov/books/NBK519008", size: 18, font: "Calibri", color: DARKGRAY })],
}),
new Paragraph({
spacing: { before: 60, after: 60 },
children: [new TextRun({ text: "7. PMC β Resurgence of pertussis: Epidemiological trends, contributing factors (2025). pmc.ncbi.nlm.nih.gov/articles/PMC12153400", size: 18, font: "Calibri", color: DARKGRAY })],
}),
new Paragraph({
spacing: { before: 60, after: 60 },
children: [new TextRun({ text: "8. MDPI Vaccines β Routine DTP Vaccination Coverage and Herd Immunity Against Pertussis in 2024. mdpi.com/2076-393X/14/3/264", size: 18, font: "Calibri", color: DARKGRAY })],
}),
],
}],
});
Packer.toBuffer(doc).then(buffer => {
fs.writeFileSync("/home/daytona/workspace/pertussis-factsheet/Pertussis_Epidemiology_Fact_Sheet.docx", buffer);
console.log("SUCCESS: Document written.");
});
cd /home/daytona/workspace/pertussis-factsheet && node generate.js
python /home/daytona/skills/docx/scripts/office/validate.py /home/daytona/workspace/pertussis-factsheet/Pertussis_Epidemiology_Fact_Sheet.docx
cd /home/daytona/workspace/pertussis-factsheet && python3 -c " import zipfile, os with zipfile.ZipFile('Pertussis_Epidemiology_Fact_Sheet.docx', 'r') as z: names = z.namelist() print('Files in docx:', names) # Check document.xml exists and is non-empty size = len(z.read('word/document.xml')) print('document.xml size:', size, 'bytes') "
Pertussis Epidemiology Fact Sheet
Word Document Β· DOCX